Tatsis Ourania 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2026-01-07$474.99/sh−4,500$2,137,455→ 42,293 total
Footnotes (1)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.